Clinical Trial Update: Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating needling with or without corticosteroids for repigmentation in vitiligo has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Vitiligo | Phase 2, Phase 3 | Status: TERMINATED